1 results match your criteria: "Gansu Maternity and Child-Care Hospital[Affiliation]"
Evaluation of the clinical effects of non-invasive prenatal screening for diseases associated with aneuploidy and copy number variation.
Mol Genet Genomic Med
September 2023
Medical Genetic Centre, Gansu Maternity and Child-Care Hospital, Lanzhou, China.
Background: To explore and compare the clinical effects of high-resolution non-invasive prenatal screening (NIPS-Plus) for common/uncommon chromosomal aneuploidy and microdeletion/microduplication syndromes (MMS).
Methods: The current prospective study included a total of 25,380 pregnant women who performed NIPS-Plus, and amniocentesis was performed on women with MMS with the screening results to diagnose patients with suspected MMS.
Results: There were 415 samples with positive results for NIPS-Plus, included 275 with aneuploidy and 140 with MMS.